In a recent study published in PNAS, researchers investigated the selective activity of sigmoid 2 receptor (σ2R) or transmembrane protein 97 (TMEM97) ligands on murine neuropathic pain models, their ...

Eighty-nine percent of patients with CP have one or more documented pain diagnoses; 38.8% of patients had nociceptive pain only. HealthDay News — Most patients (89%) with cerebral palsy (CP) have one ...

Pain management is a tricky area for physicians: they don’t want patients suffering, but current treatment options are limited, with highly addictive opioids one of the few available resources.

A review published in Arthritis Care & Research serves as a tool for managing nociplastic pain in patients with rheumatic diseases. The authors looked at the three general categories of pain: ...

Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what kind ...

Neuropathic pain in individuals with cancer remains a challenging clinical problem that requires advanced pharmacologic skills and a clear understanding of the molecular mechanisms that drive it. At ...

Pain, often rated as the most significant symptom of hidradenitis suppurativa (HS), can substantially reduce quality of life and increase the risk of disability and chronic opioid use. Although the ...

Pain management is a crucial part of the disease's care, but little is understood about how to manage it properly. Pain management is an important component of caring for adults with cerebral palsy.